[Etiology and Antimicrobial Resistance of Uncomplicated Urinary Tract Infections]
Overview
Authors
Affiliations
Uncomplicated urinary tract infections rank among the most frequent bacterial infections in women in the outpatient setting and represent a major cause of antimicrobial prescription. The aims of this study were to assess frequencies and antimicrobial resistance of current uropathogens causing uncomplicated urinary tract infection. In a prospective multicenter study, patients were recruited in ambulatory settings of four participating hospitals between June 2011 and December 2013. We analyzed 138 patients that met clinical and bacteriological diagnostic criteria. The mean age was 28 years. Cystitis was defined in 70% (n: 97) and pyelonephritis in 30% (n: 41). Frequencies of isolated microorganisms were: Escherichia coli 70% (n: 97), Staphylococcus saprophyticus 17% (n: 24), Proteus spp. 7% (n: 10), Klebsiella spp. 4% (n: 5), Enterococcus spp. and Pseudomonas aeruginosa 1 (0.7%) each. The antimicrobial resistance was: ampicillin-sulbactam 37% (n: 51) cephalexin 28% (n: 39), trimethoprim/sulfamethoxazole 22% (n: 31), nitrofurantoin 12% (n: 17), gentamicin 7% (n: 10) and ciprofloxacin 5% (n: 7). The levels of resistance found for ampicillin-sulbactam, trimethoprim/sulfamethoxazole and cephalexin were higher than those previously reported in Argentina. A better knowledge of the etiology and local antimicrobial susceptibility allows the design of more adequate guidelines for empirical treatment.
Vilella P, Maldonado J, Fernandez P, Flores M, De Bernardi C, Vilte Velazquez K Rev Fac Cien Med Univ Nac Cordoba. 2023; 80(4):476-498.
PMID: 38150202 PMC: 10851398. DOI: 10.31053/1853.0605.v80.n4.41244.
Disease burden and long-term trends of urinary tract infections: A worldwide report.
Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F Front Public Health. 2022; 10:888205.
PMID: 35968451 PMC: 9363895. DOI: 10.3389/fpubh.2022.888205.
Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons.
Hoellein L, Kaale E, Mwalwisi Y, Schulze M, Vetye-Maler C, Holzgrabe U Risk Manag Healthc Policy. 2022; 15:827-843.
PMID: 35519501 PMC: 9064051. DOI: 10.2147/RMHP.S205077.